Skip to main content
Home
Twitter
Flickr
Youtube
Share

Main navigation

  • About
  • Countries
  • Focus Areas
  • Diseases
  • Sustainability
  • Resources
  • News
  • Contact US
Image
Map Burkina Faso
Burkina Faso
Accomplishments
89 percent

Burkina Faso has stopped mass drug administration (MDA) for lymphatic filariasis in 89% of endemic districts in the country following the likely interruption of transmission of the causative parasite in 62 districts as of FY21 (October 2020 – September 2021). Prevalence of infection has been reduced significantly in the remaining eight districts due to ongoing MDA.  

TF Less than 5 percent

All trachoma endemic health districts have reached the elimination threshold of trachomatous inflammation—follicular (TF) of less than 5% among children ages 1-9 and have stopped MDA as of FY18 (October 2017 – September 2018).

80 percent

Two rounds of onchocerciasis MDA implemented each year for the past four years resulted in 80% epidemiological coverage in FY22 (October 2021 – September 2022). 

20 districts

Burkina Faso has implemented MDA against SCH/STH since 2004. After successfully reducing STH prevalence through MDA, the WHO recommended stopping STH MDA throughout the country in 2021. Burkina Faso continues to provide deworming treatment to children under 5 and pregnant women. As a result of eight to nine rounds of high coverage MDA, Burkina Faso will conduct a schistosomiasis (and soil-transmitted helminthiasis) impact assessment in 20 districts in 2023.

Standard Disease-Specific Indicators as of FY21

FY21 is October 2020 through September 2021

LYMPHATIC FILARIASIS
89 percent

of ever-endemic districts have stopped MDA as of FY21

(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))

43 percent

of ever-endemic districts in post-surveillance phase as of FY21

(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))

91 percent

of persons no longer at risk as of FY21 among those who were ever at risk

TRACHOMA
100%

of ever-endemic districts have stopped MDA as of FY21

(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))

Pills

77 percent

of ever-endemic districts in post-MDA surveillance phase as of FY21

(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))*

*Burkina Faso conducted TSS in 36 HDs by the end of FY21 with results pending in one additional district.

100%

of persons no longer at risk as of FY21 among those who were ever at risk

Onchoceriasis
100%

of ever endemic districts have been treated at least once as of FY21

(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)

Schistosomiasis
100%

of ever endemic districts have been treated at least once as of FY21

SOIL-TRANSMITTED Helminthiasis
100%

of ever endemic districts have been treated at least once as of FY21

Sign up to receive updates

Wanting to know more about Act to End NTDs | West?

You can subscribe to receive our e-newsletter.

The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.

USAID

Act to End NTDs West

FHI360

© 2023 All rights reserved.